Annexin II overexpression predicts rapid recurrence after surgery in pancreatic cancer patients undergoing gemcitabine-adjuvant chemotherapy

Annals of Surgical Oncology
Shigetsugu TakanoMasaru Miyazaki

Abstract

Gemcitabine has been shown to exhibit significant clinical activity against pancreatic cancer and has become a first-line chemotherapeutic for this disease in recent years. However, there are still many patients who do not respond to this treatment and it is expected to improve the clinical outcome if we can develop a method to predict the efficacy of gemcitabine before treatment. The purpose of this study was to determine novel factors that make pancreatic cancer resistant to gemcitabine. Using the high-resolution proteomic approach, agarose two-dimensional gel electrophoresis, we compared protein profiling of a gemcitabine-resistant pancreatic cancer cell line with its wild-type. We identified Annexin II as an up-regulated protein in the gemcitabine-resistant pancreatic cancer cell line. Immunohistochemistry demonstrated that Annexin II was mainly expressed at the cell surface of pancreatic cancer cells. Interestingly, Annexin II overexpression in cancer cells was significantly associated with rapid recurrence after gemcitabine adjuvant chemotherapy in postoperative patients (P = .0078), and its staining was also an independent prognostic indicator of recurrence in pancreatic cancer patients who underwent adjuvant gemcitabine...Continue Reading

References

Jun 1, 1990·Molecular and Cellular Biology·M FrohlichM Ozturk
Oct 7, 1988·Cell·M R CromptonM J Crumpton
Mar 1, 1993·Differentiation; Research in Biological Diversity·R Schwartz-AlbiezG Wirl
Apr 15, 1997·Annals of the New York Academy of Sciences·K A Hajjar, J S Menell
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H A BurrisD D Von Hoff
Apr 16, 1998·Journal of Neuro-oncology·S J NygaardO B Tysnes
Aug 26, 1998·British Journal of Cancer·J Carmichael
Apr 1, 1999·The New England Journal of Medicine·J S MenellK A Hajjar
Jan 20, 2000·Trends in Cardiovascular Medicine·K A Hajjar, S Krishnan
Dec 3, 2002·Nature Reviews. Cancer·Nabeel Bardeesy, Ronald A DePinho
Mar 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Takeshi TomonagaFumio Nomura
Sep 7, 2005·Seminars in Oncology·Donald A Richards
Feb 2, 2006·The Journal of Pathology·I EspositoP Schirmacher
Mar 21, 2006·Acta Oncologica·Magnus Bergenfeldt, Maria Albertsson
Apr 28, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Valeria SebastianiChristine A Iacobuzio-Donahue
Oct 3, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Valentin GirouxJean-Charles Dagorn
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio C WolffUNKNOWN College of American Pathologists
Apr 25, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malcolm J MooreUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Nov 17, 2007·Molecular and Cellular Biochemistry·Yun HuangSong-Bin Fu

❮ Previous
Next ❯

Citations

Dec 19, 2009·The Journal of Biological Chemistry·Kamala KesavanDouglas B Jacoby
Aug 4, 2011·PloS One·Fred ReynoldsKimberly A Kelly
Sep 13, 2011·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Noor A LokmanCarmela Ricciardelli
Feb 26, 2013·International Journal of Molecular Sciences·Patrícia A Madureira, David M Waisman
Mar 27, 2013·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·C-H LuoY-F Liu
Mar 12, 2015·Oncology Reports·Xiao-Heng XuYan-Qiu Song
Jun 26, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Haijian ZhangDengfu Yao
Oct 17, 2009·Proteomics·Ingrid MillerElisabetta Gianazza
Sep 25, 2012·Molecular Carcinogenesis·Harumi HataToshio Nakadate
Apr 19, 2013·Experimental Hematology & Oncology·Patrizia CerutiFrancesco Novelli
Jun 26, 2012·The Journal of Surgical Research·Shingo KagawaMasaru Miyazaki
Aug 25, 2012·Genomics, Proteomics & Bioinformatics·Shishan DengZhengwei Yang
Feb 11, 2015·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Faruk TasDerya Duranyildiz
Mar 23, 2013·International Journal of Molecular Sciences·Alamelu BharadwajDavid Waisman
Mar 31, 2018·Journal of Biomedical Science·Chang-Yu ChenYin-Ju Chen
Aug 21, 2018·International Journal of Cancer. Journal International Du Cancer·Mahesh C Sharma
Aug 18, 2017·Journal of Experimental & Clinical Cancer Research : CR·Yi WangYeming Wu
Dec 12, 2013·Pancreas·Kathryn T ChenAnthony T Yeung
Aug 12, 2020·Cancer Metastasis Reviews·Leela Rani AvulaChristine Alewine
Nov 9, 2017·International Journal of Oncology·Maria V ChristensenEstrid V S Høgdall
Mar 23, 2019·Journal of Experimental & Clinical Cancer Research : CR·Weining WuYingyi Wang
Dec 22, 2011·Oncotarget·Patricia Alexandra MadureiraDavid Morton Waisman
Mar 30, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nigel B JamiesonKarin A Oien

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Suebwong ChuthapisithOleg Eremin
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society
Noor A LokmanCarmela Ricciardelli
International Journal of Cancer. Journal International Du Cancer
Junichi InokuchiDarren R Tyson
© 2022 Meta ULC. All rights reserved